Correction to: Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation (British Journal of Pharmacology, (2006), 149, (1092-1103), 10.1038/sj.bjp.0706945);Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation

British Journal of Pharmacology

Volumn 149, Issue 8, 2006, Pages 1092-1103

  Chen, X ^a   Zhou, H ^b   Liu, Y B ^a   Wang, J F ^b   Li, H ^b   Ung, C Y ^b   Han, L Y ^b   Cao, Z W ^c   Chen, Y Z ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

Author keywords

Chinese medicinal plant; Drug; Herbal formula; Herbal medicine; Natural product; Pharmaceuticals

Indexed keywords

BAICALIN; CAMPESTEROL; CHINESE DRUG; E JIAO BU XUE GAO; GENISTEIN; GINSENG EXTRACT; GINSENOSIDE RG 1; GUI ZHI HE JI; HUANG QI JIAN ZHONG WAN; HUANG QI SHENG MAI YIN; KU HUANG ZHU SHE YE; LIANG GE HE JI; LIU JUN ZI WAN; PALMITIC ACID; QING DAI SAN; QING GAN LI DAN KOU FU YE; REHMAGLUTIN A; REHMANNIA EXTRACT; SHI QUAN DA BU JIU; UNINDEXED DRUG; WEN PI ZHI XIE WAN; WEN WEI SHU CHONG JI; WU JI BAI FENG WAN; XIAO CHAI HU WAN; XIAO JIAN ZHONG CHONG JI; XIAO QING LONG HE JI; XU HAN WEI TONG CHONG JI; YIN PU JIE DU PIAN; YIN ZHI HUANG ZHU SHE YE; ZHI GAN CAO HE JI;

ARTICLE; BIBLIOGRAPHIC DATABASE; CHINESE MEDICINE; COMPUTER MODEL; COMPUTER PROGRAM; DRUG ACTIVITY; DRUG INDICATION; DRUG INFORMATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; HERB; INFORMATION PROCESSING; MEDICAL LITERATURE; MEDLINE; PRESCRIPTION; PRIORITY JOURNAL; SYSTEMS BIOLOGY; THERAPY EFFECT; VALIDATION STUDY; VALIDITY;

EID: 33845618105     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.15297     Document Type: Erratum

References (85)

1. Attele AS, Wu JA, Yuan CS (1999). Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 58: 1685-1693.
2. Barnes S, Boersma B, Patel R, Kirk M, Darley-Usmar VM, Kim H et al. (2000). Isoflavonoids and chronic disease: mechanisms of action. Biofactors 12: 209-215.
3. Barnes S, Peterson TG (1995). Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med 208: 103-108.
4. Bensoussan A, Myers SP, Drew AK, Whyte IM, Dawson AH (2002). Development of a Chinese herbal medicine toxicology database. J Toxicol Clin Toxicol 40: 159-167.
5. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H et al. (2000). The Protein Data Bank. Nucleic Acids Res 28: 235-242.
6. Bhuiyan MB, Fant ME, Dasgupta A (2003). Study on mechanism of action of Chinese medicine Chan Su: dose-dependent biphasic production of nitric oxide in trophoblastic BeWo cells. Clin Chim Acta 330: 179-184.
7. Byvatov E, Schneider G (2003). Support vector machine applications in bioinformatics. Appl Bioinformatics 2: 67-77.
8. Castle EP, Thrasher JB (2002). The role of soy phytoestrogens in prostate cancer. Urol Clin North Am 29: 71-81, viii-ix.
9. Chan K (1995). Progress in traditional Chinese medicine. Trends Pharmacol Sci 16: 182-187.
10. Chen Q (1998). Pharmacology and Clinical Studies of Well-known Traditional Chinese Medicinal Recipes. People Health Pub. Co: Beijing.
11. Chen X, Ung CY, Chen Y (2003). Can an in silico drug-target search method be used to probe potential mechanisms of medicinal plant ingredients? Nat Prod Rep 20: 432-444.
12. Chen Y, Ung C (2002). Computer automated prediction of putative therapeutic and toxicity protein targets of bioactive compounds from Chinese medicinal plants. Am J Chin Med 30: 139-154.
13. Chen YZ, Ung CY (2001). Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach. J Mol Graph Model 20: 199-218.
14. Chen YZ, Zhi DG (2001). Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins 43: 217-226.
15. Cheng JT (2000). Review: drug therapy in Chinese traditional medicine. J Clin Pharmacol 40: 445-450.
16. Cho SW, Cho EH, Choi SY (1995). Ginsenosides activate DNA polymerase delta from bovine placenta. Life Sci 57: 1359-1365.
17. Danieli B, Falcone L, Monti D, Riva S, Gebhardt S, Schubert-Zsilavecz M (2001). Regioselective enzymatic glycosylation of natural polyhydroxylated compounds: galactosylation and glucosylation of protopanaxatriol ginsenosides. J Org Chem 66: 262-269.
18. De Clercq E (2000). Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med Res Rev 20: 323-349.
19. Dluzewski AR, Garcia CR (1996). Inhibition of invasion and intraerythrocytic development of Plasmodium falciparum by kinase inhibitors. Experientia 52: 621-623.
20. Evans BA, Griffiths K, Morton MS (1995). Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 147: 295-302.
21. Fajardo I, Quesada AR, Nunez de Castro I, Sanchez-Jimenez F, Medina MA (1999). A comparative study of the effects of genistein and 2-methoxyestradiol on the proteolytic balance and tumour cell proliferation. Br J Cancer 80: 17-24.
22. Flamigni F, Facchini A, Capanni C, Stefanelli C, Tantini B, Caldarera CM (1999). p44/42 mitogen-activated protein kinase is involved in the expression of ornithine decarboxylase in leukaemia L1210 cells. Biochem J 341: 363-369.
23. He M, Yan X, Zhou J, Xie G (2001). Traditional Chinese medicine database and application on the Web. J Chem Inf Comput Sci 41: 273-277.
24. Huang TK (1999). Handbook of Composition and Pharmacological Action of Commonly Used Traditional Chinese Medicine. Chin. Med. Sci. Pub Co: Shanghai.
25. Huo YS, Zhang SC, Zhou D, Yao DL, You GY, Zhang HW et al. (1986). Pharmacokinetics and tissue distribution of [3H]ginsenoside Rg1. Zhongguo Yao Li Xue Bao 7: 519-521.
26. Ikemoto S, Sugimura K, Yoshida N, Yasumoto R, Wada S, Yamamoto K et al. (2000). Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology 55: 951-955.
27. Ji YB (1994). Pharmacological Action and Application of Available Composition of Traditional Chinese Medicine. HeiLongJiang Sci. Tech. Pub. Co: Harbin.
28. Ji ZL, Zhou H, Wang JF, Han LY, Zheng CJ, Chen YZ (2006). Traditional Chinese medicine information database. 103: 501.
29. Johnson RA, Wichern DW (2002). Applied Multivariate Statistical Analysis. Prentice Hall: New Jersey.
30. Kato M, Liu W, Yi H, Asai N, Hayakawa A, Kozaki K et al. (1998). The herbal medicine Sho-saiko-to inhibits growth and metastasis of malignant melanoma primarily developed in ret-transgenic mice. J Invest Dermatol 111: 640-644.
31. Kawa-uchi T, Nifuji A, Mataga N, Olson EN, Bonaventure J, Shinomiya K et al (1998). Fibroblast growth factor downregulates expression of a basic helix-loop-helix-type transcription factor, scleraxis, in a chondrocyte-like cell line, TC6. J Cell Biol 70: 468-477.
32. Kenarova B, Neychev H, Hadjiivanova C, Petkov VD (1990). Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Japanese J Pharmacol 54: 447-454.
33. Kikuchi H, Hossain A (1999). Signal transduction-mediated CYP1A1 induction by omeprazole in human HepG2 cells. Exp Toxicol Pathol 51: 342-346.
34. Kim MH, Albertsson P, Xue Y, Nannmark U, Kitson RP, Goldfarb RH (2001). Expression of neutrophil collagenase (MMP-8) in Jurkat T leukemia cells and its role in invasion. Anticancer Res 21: 45-50.
35. Kitamura K, Honda M, Yoshizaki H, Yamamoto S, Nakane H, Fukushima M et al. (1998). Baicalin, an inhibitor of hiv-1 production in vitro. Antiviral Res 37: 131-140.
36. Kitts D, Hu C (2000). Efficacy and safety of ginseng. Public Health Nutr 3: 473-485.
37. Kniss DA, Zimmerman PD, Su HC, Fertel RH (1996). Genistein suppresses EGF-induced prostaglandin biosynthesis by a mechanism independent of EGF receptor tyrosine kinase inhibition. Prostaglandins 51: 87-105.
38. Kulling SE, Metzler M (1997). Induction of micronuclei, DNA strand breaks and HPRT mutations in cultured Chinese hamster V79 cells by the phytoestrogen coumoestrol. Food Chem Toxicol 35: 605-613.
39. Kuzumaki T, Kobayashi T, Ishikawa K (1998). Genistein induces p21(Cip1/WAF1) expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells. Biochem Biophys Res Commun 251: 291-295.
40. 2+ elevation by reducing phospholipase C activity in C6 rat glioma cells. J Pharmacy Pharmacol 50: 1179-1182.
41. Lazar MA (2004). East meets West: an herbal tea finds a receptor. J Clin Invest 113: 23-25.
42. Lee KY, Lee SK (1996). Ginsenoside-Rg1 positively regulates cyclin E-dependent kinase activity in human hepatoma SK-HEP-1 cells. Biochem Mol Biol Int 39: 539-546.
43. Li JQ, Li ZK, Duan H, Zhang JT (1997). Effect of age and ginsenoside Rg1 on nitric oxide content and nitric oxide synthase activity of cerebral cortex in rats. Yao xue xue bao 32: 251-254.
44. Lin CC, Shieh DE (1996). The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med 24: 31-36.
45. Liu W, Kato M, Akhand AA, Hayakawa A, Takemura M, Yoshida S et al. (1998). The herbal medicine sho-saiko-to inhibits the growth of malignant melanoma cells by upregulating Fas-mediated apoptosis and arresting cell cycle through downregulation of cyclin dependent kinases. Int J Oncol 12: 1321-1326.
46. Majumder SK, Ghosh N, Gupta PK (2005). Support vector machine for optical diagnosis of cancer. J Biomed Opt 10: 024034.
47. Martel-Pelletier J, Mineau F, Jovanovic D, Di Battista JA, Pelletier JP (1999). Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated protein kinase (MAPKAPK). Arthritis Rheumat 42: 2399-2409.
48. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T et al. (2001). Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharmaceut Bull 24: 351-356.
49. Munoz R, Klingenberg O, Wiedlocha A, Rapak A, Falnes PO, Olsnes S (1997). Effect of mutation of cytoplasmic receptor domain and of genistein on transport of acidic fibroblast growth factor into cells. Oncogene 15: 525-536.
50. Nagai T, Yamada H, Otsuka Y (1989). Inhibition of mouse liver sialidase by the root of Scutellaria baicalensis. Planta Med 55: 27-29.
51. Nakahata N, Kutsuwa M, Kyo R, Kubo M, Hayashi K, Ohizumi Y (1998). Analysis of inhibitory effects of scutellariae radix and baicalein on prostaglandin E2 production in rat C6 glioma cells. Am J Chin Med 26: 311-323.
52. Nishimura J, Takahira H, Shibata K, Muta K, Yamamoto M, Ideguchi H et al. (1988). Regulation of biosynthesis and phosphorylation of P210bcr/abl protein during differentiation induction of K 562 cells. Leuk Res 12: 875-885.
53. Orie NN, Zidek W, Tepel M (2000). creased intracellular generation of reactive oxygen species in mononuclear leukocytes from patients with diabetes mellitus type 2. Exp Clin Endocrinol Diabetes 108: 175-180.
54. Pach D, Willich SN, Becker-Witt C (2002). Availability of research results on traditional Chinese pharmacotherapy. Forsch Komplementarmed Klass Naturheilkd 9: 352-358.
55. Pan W, Ikeda K, Takebe M, Yamori Y (2001). Genistein, daidzein and glycitein inhibit growth and DNA synthesis of aortic smooth muscle cells from stroke-prone spontaneously hypertensive rats. J Nutr 131: 1154-1158.
56. Pang SD (2000). Handbook of Newly Compiled TCM Prescriptions. Jiangxi Sci. Tech. Pub. Co: Nanchang.
57. Pecherskaya A, Solem M (2000). IGF1 activates PKC alpha-dependent protein synthesis in adult rat cardiomyocytes. Molecular Cell Biol Res Commun 4: 166-171.
58. Polkowski K, Mazurek AP (2000). Biological properties of genistein. A review of in vitro and in vivo data. Acta Pol Pharm 57: 135-155.
59. Qiao X, Hou T, Zhang W, Guo S, Xu X (2002). A 3D structure database of components from Chinese traditional medicinal herbs. J Chem Inf Comput Sci 42: 481-489.
60. Reyes-Cruz G, Vazquez-Prado J, Muller-Esterl W, Vaca L (2000). Regulation of the human bradykinin B2 receptor expressed in sf21 insect cells: a possible role for tyrosine kinases. J Cell Biochem 76: 658-673.
61. Sadowska-Krowicka H, Mannick EE, Oliver PD, Sandoval M, Zhang XJ, Eloby-Childess S et al. (1998). Genistein and gut inflammation: role of nitric oxide. Proc Soc Exp Biol Med 217: 351-357.
62. Schmidt TJ, Meyer AS (1994). Autoregulation of corticosteroid receptors How, when, where, and why? Receptor 4: 229-257.
63. Shin HR, Kim JY, Yun TK, Morgan G, Vainio H (2000). The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control 11: 565-576.
64. Su WW (1997). Computer-aided analysis of Traditional Chinese Medicine. China J Chin Materia Medica 22: 186-188.
65. Swa S, Wright H, Thomson J, Reid H, Haig D (2001). Constitutive activation of Lck and Fyn tyrosine kinases in large granular lymphocytes infected with the gamma-herpesvirus agents of malignant catarrhal fever. Immunology 102: 44-52.
66. Takahashi T, Kawahara Y, Okuda M, Ueno H, Takeshita A, Yokoyama M (1997). Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells. J Biol Chem 272: 16018-16022.
67. Takino Y (1994). Studies on the pharmacodynamics of ginsenoside-Rg1, -Rb1 and -Rb2 in rats. Yakugaku Zasshi 114: 550-564.
68. Tang W, Eisenbrand G (1992). Chinese Drugs of Plant Origin: Chemistry, Pharmacology and Use in Traditional and Modern Medicine. Springer-Verlag: Berlin.
69. Theodorescu D, Laderoute KR, Calaoagan JM, Guilding KM (1998). Inhibition of human bladder cancer cell motility by genistein is dependent on epidermal growth factor receptor but not p21ras gene expression. Int J Cancer 78: 775-782.
70. Tomobe K, Philbrick DJ, Ogborn MR, Takahashi H, Holub BJ (1998). Effect of dietary soy protein and genistein on disease progression in mice with polycystic kidney disease. Am J Kid Dis 31: 55-61.
71. Uckun FM, Evans WE, Forsyth CJ, Waddick KG, Ahlgren LT, Chelstrom LM et al. (1995). Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 267: 886-891.
72. Wang JF, Cai CZ, Kong CY, Cao ZW, Chen YZ (2005a). A computer method for validating traditional Chinese medicine herbal prescriptions. Am J Chin Med 33: 281-297.
73. Wang JF, Zhou H, Han LY, Chen X, Chen YZ, Cao ZW (2005b). Traditional Chinese medicine information database. Clin Pharmacol Therapeut 78: 92-93.
74. Wang L, Higashiura K, Ura N, Miura T, Shimamoto K (2003). Chinese medicine, Jiang-Tang-Ke-Li, improves insulin resistance by modulating muscle fiber composition and muscle tumor necrosis factor-alpha in fructose-fed rats. Hypertens Res 26: 527-532.
75. Wheeler DL, Church D.M, Federhen S, Lash A E, Madden T L, Pontius J U et al. (2003). Database resources of the National Center for Biotechnology. Nucleic Acids Res 31: 28-33.
76. Wu J, Chen D, Zhang R (1999). Study on the bioavailability of baicalin-phospholipid complex by using HPLC. Biomed Chromatogr 13: 493-495.
77. Xu H, Markatou M, Dimova R, Liu H, Friedman C (2006). Machine learning and word sense disambiguation in the biomedical domain: design and evaluation issues. BMC Bioinform 7: 334.
78. 2+ elevation and contraction in iris sphincter smooth muscle. Eur J Pharmacol 360: 185-193.
79. Yu J, Chen XW (2005). Bayesian neural network approaches to ovarian cancer identification from high-resolution mass spectrometry data. Bioinformatics 21 (Suppl 1): i487-i494.
80. Yuan R, Lin Y (2000). Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol Ther 86: 191-198.
81. Zhang E (1988). Highly Efficacious Chinese Patent Medicines. Shanghai Univ. Tradi. Chin. Med. Pub. Co: Shanghai.
82. Zhang E (1998). Prescriptions of Traditional Chinese Medicine.. Shanghai Univ. Tradi. Chin. Med. Pub. Co: Shanghai.
83. Zhang L, Lin G, Chang Q, Zuo Z (2005). Role of intestinal first-pass metabolism of baicalein in its absorption process. Pharmaceut Res 22: 1050-1058.
84. Zhou YP, Zhang JQ (1989). Oral baicalin and liquid extract of licorice reduce sorbitol levels in red blood cell of diabetics rats. Chinese Med J 102: 203-206.
85. Zuo F, Zhou ZM, Yan MZ, Liu ML, Xiong YL, Zhang Q et al (2002). Metabolism of constituents in Huangqin-Tang, a prescription in traditional Chinese medicine, by human intestinal flora. Biol Pharmaceut Bull 25: 558-563.